{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:10:29Z","timestamp":1791850229766,"version":"4.3.4"},"reference-count":49,"publisher":"Massachusetts Medical Society","issue":"9","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K23 HD088230"],"award-info":[{"award-number":["K23 HD088230"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01 HD080471"],"award-info":[{"award-number":["R01 HD080471"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2019,8,29]]},"DOI":"10.1056\/nejmoa1905230","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T11:09:12Z","timestamp":1563793752000},"page":"827-840","source":"Crossref","is-referenced-by-count":353,"title":["Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana"],"prefix":"10.1056","volume":"381","author":[{"given":"Rebecca","family":"Zash","sequence":"first","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Holmes","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modiegi","family":"Diseko","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise L.","family":"Jacobson","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Brummel","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Mayondi","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle","family":"Isaacson","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Davey","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Mabuta","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mompati","family":"Mmalane","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tendani","family":"Gaolathe","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Essex","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Lockman","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Makhema","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"From the Division of Infectious Diseases, Beth Israel Deaconess Medical Center (R.Z., R.L.S.), the Department of Immunology and Infectious Diseases (R.Z., M.E., S.L., J. Makhema, R.L.S.) and the Center for Biostatistics in AIDS Research (D.L.J., S.B.), Harvard T.H. Chan School of Public Health, MassGeneral Hospital for Children, Massachusetts General Hospital (L.H.), and the Division of Infectious Diseases, Brigham and Women\u2019s Hospital (S.L.) \u2014 all in Boston; the Botswana\u2013Harvard AIDS Institute..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199911113412006"},{"issue":"3","key":"e_1_3_5_3_2","first-page":"12","article-title":"Efavirenz pregnancy warning.","volume":"12","author":"Cadman J","year":"1998","unstructured":"Cadman J. Efavirenz pregnancy warning. GMHC Treat Issues 1998;12(3):12-12.11365392","journal-title":"GMHC Treat Issues"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.3.355"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200201250-00025"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7211343"},{"key":"e_1_3_5_7_2","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/QAD.0000000000000231","article-title":"Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.","volume":"28","author":"Ford N","year":"2014","unstructured":"Ford N, Mofenson L, Shubber Z, et al. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis. AIDS 2014;28:Suppl 2:S123-S131.24849471","journal-title":"AIDS"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001845"},{"key":"e_1_3_5_9_2","unstructured":"Handbook of the Botswana 2016 integrated HIV clinical care guidelines. Gaborone: Botswana Ministry of Health 2016 (https:\/\/aidsfree.usaid.gov\/sites\/default\/files\/botswana_art_2016.pdf)."},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1807653"},{"key":"e_1_3_5_11_2","unstructured":"New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir. Amsterdam: European Medicines Agency May 18 2018 (https:\/\/www.ema.europa.eu\/en\/news\/new-study-suggests-risk-birth-defects-babies-born-women-hiv-medicine-dolutegravir)."},{"key":"e_1_3_5_12_2","unstructured":"FDA drug safety communication: FDA to evaluate potential risk of neural tube birth defects with HIV medicine dolutegravir (Juluca Tivicay Triumeq). Silver Spring MD: Food and Drug Administration September 2018 (https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-evaluate-potential-risk-neural-tube-birth-defects-hiv-medicine)."},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.2222"},{"key":"e_1_3_5_14_2","unstructured":"Health statistics report 2010. Gaborone: Statistics Botswana November 2017 (www.statsbots.org.bw\/sites\/default\/files\/publications\/Health%20Statistics%20Report%202010.pdf)."},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60932-6"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00384-6"},{"key":"e_1_3_5_17_2","unstructured":"Safety issues affecting women living with HIV using dolutegravir at the time of conception: advice for healthcare workers. Gaborone: Botswana Ministry of Health and Wellness May 24 2018."},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.2307\/2685469"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30218-3"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi188"},{"key":"e_1_3_5_22_2","unstructured":"Tivicay: dolutegravir (DTG): New Drug Application (NDA) 204790. Drugs@FDA: FDA approved drug products. Silver Spring MD: Food and Drug Administration August 6 2013 (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2013\/204790Orig1S000SumR.pdf)."},{"key":"e_1_3_5_23_2","unstructured":"Antiretroviral Pregnancy Registry Steering Committee. The Antiretroviral Pregnancy Registry interim report for 1 January 1989 through 31 January 2019. Wilmington NC: Registry Coordinating Center June 2019 (http:\/\/www.apregistry.com\/forms\/interim_report.pdf)."},{"key":"e_1_3_5_24_2","unstructured":"Chandiwana N Hill A Chersich M et al. Serum folate and birth outcomes: DTG vs EFV trial evidence in South Africa. Presented at the Conference on Retroviruses and Opportunistic Infections (CROI) Seattle March 4\u20137 2019."},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001931"},{"key":"e_1_3_5_26_2","first-page":"e25187","article-title":"Exposure to dolutegravir in pregnant HIV-positive women in Central and Eastern Europe and neighbouring countries: data from the ECEE Network Group. Presented at HIV Glasgow, Glasgow, United Kingdom, October 28\u201331, 2018.","volume":"21","author":"Kowalska J","year":"2018","unstructured":"Kowalska J, G\u00f6kengin D, Aho I, et al. Exposure to dolutegravir in pregnant HIV-positive women in Central and Eastern Europe and neighbouring countries: data from the ECEE Network Group. Presented at HIV Glasgow, Glasgow, United Kingdom, October 28\u201331, 2018. J Int AIDS Soc 2018;21:Suppl 8:e25187-e25187.","journal-title":"J Int AIDS Soc"},{"key":"e_1_3_5_27_2","first-page":"e25187","article-title":"An analysis of congenital abnormalities in pregnant women living with HIV in Canada: no signal for neural tube defects in women exposed to dolutegravir.","volume":"21","author":"Money D","year":"2018","unstructured":"Money D, Lee T, Farjou G, et al. An analysis of congenital abnormalities in pregnant women living with HIV in Canada: no signal for neural tube defects in women exposed to dolutegravir. J Int AIDS Soc 2018;21:Suppl 8:e25187-e25187.","journal-title":"J Int AIDS Soc"},{"key":"e_1_3_5_28_2","unstructured":"Sibiude J Le Chenadec J Mandelbrot L et al. No increase in birth defects in infants exposed to integrase inhibitors at conception. Presented at the Conference on Retroviruses and Opportunistic Infections Seattle (CROI) March 4\u20137 2019."},{"key":"e_1_3_5_29_2","first-page":"e25187","article-title":"Use of integrase inhibitors in HIV-positive pregnant women: data from the Frankfurt HIV Cohort.","volume":"21","author":"Weissmann D","year":"2018","unstructured":"Weissmann D, De Leuw P, Gute P, et al. Use of integrase inhibitors in HIV-positive pregnant women: data from the Frankfurt HIV Cohort. J Int AIDS Soc 2018;21:Suppl 8:e25187-e25187.","journal-title":"J Int AIDS Soc"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3195-9"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002065"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(17)30095-4"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-0592"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002289"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.119.087635"},{"key":"e_1_3_5_36_2","unstructured":"Periconceptional folic acid supplementation to prevent neural tube defects. Geneva: World Health Organization February 11 2019 (https:\/\/www.who.int\/elena\/titles\/folate_periconceptional\/en\/)."},{"key":"e_1_3_5_37_2","unstructured":"Behrman R Butler A eds. Preterm birth: causes consequences and prevention. Washington DC: National Academies Press 2007."},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3868"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2016.02.012"},{"key":"e_1_3_5_40_2","unstructured":"Davey S Ajibola G Sakoi M et al. In utero mother-to-child transmission (MTCT) in Botswana does not differ between efavirenz\/tenofovir\/emtricitabine (EFV\/TDF\/FTC) and dolutegravir\/tenofovir\/emtricitabine (DTG\/TDF\/FTC). Presented at the 10th IAS Conference on HIV Science Mexico City July 21\u201324 2019."},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwk027"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000268"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/ppe.12073"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.7326\/M18-3358"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30317-5"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.7326\/M19-0641"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001214"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2017.6857"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2016.1226281"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30272-9"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1905230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T20:34:29Z","timestamp":1711485269000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1905230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,8,29]]}},"alternative-id":["10.1056\/NEJMoa1905230"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa1905230","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736238641.793564778","asserted-by":"object"}]},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]}}}